American Pharmacists Assn
The American Pharmacists Association (APhA, previously known as the American Pharmaceutical Association), founded in 1852, is the first-established professional society of pharmacists within the United States. . APhA is made up of more than 60,000 practicing pharmacists, pharmaceutical scientists, student pharmacists, pharmacy technicians, and others interested in advancing the profession. Through a House of Delegates that meets each year at the APhA Annual Meeting & Exposition, APhA provides a forum for discussion, consensus building, and policy setting for the profession of pharmacy. In fact, nearly all of pharmacy's specialty organizations trace their roots to APhA, having originally been a section or part of this broad foundation of pharmacy. The APhA Board of Trustees is responsible for broad direction setting of the Association. All members choose one of these three Academies when they join APhA:
Figures are based on itemized contributions reported to the Federal Election Commission and state agencies. Please note that:
- contributions under $200 are not reported, and so are not included in totals.
- only contributions from individuals and organizations to candidates are included. Various accounting measures and more exotic contribution types are excluded.
- contributions are matched based on organization and recipient name reported within each election cycle. Contributions using an incorrect or non-standard version of the name may be missed.
- corporate name changes and mergers may cause figures to differ from those of the Center for Responsive Politics.
- organization totals include known subsidiaries of the organization.
Latest FEC Datacovers through committee's December 31, 2012 filing.
Summaryoverview of the committee's finances
- Total Raised:
- Total Spent:
- Cash on Hand:
Standardized Donation Informationcovers roughly through Q3 2013. may lag behind FEC section above, as donors and industries are identified by hand.
- Employee Color Block
- PAC Color Block
Republicans vs. Democratsin dollars
State vs. Federalin dollars
Top PAC Recipients
- Employee Color Block
- PAC Color Block
Figures are based on lobbying activity reported to the Senate Office of Public Records. Reported dollar amounts are required to be accurate only to the nearest $20,000. For organizations whose primary business is lobbying, we display total income and top clients. For organizations that are not primarily lobbying firms, we display total amount spent on lobbying and top lobbying firms hired.
For more information, please see our lobbying methodology page.
Lobbying on Behalf of American Pharmacists Assn
Names of Lobbyists
Firm Hired Amount American Pharmacists Assn $1,117,843
Most Frequently Disclosed Lobbying Issues
- Health Issues,
- Fed Budget & Appropriations,
- Medicare & Medicaid
Most Frequently Disclosed Bills
Bill No. Title H.R.891 Medication Therapy Management Benefits Act of 2011 S.274 Medication Therapy Management Empowerment Act of 2011 S.48 Pharmacist Student Loan Repayment Eligibility Act of 2011 S.2 Middle Class Success Act S.30 A bill to amend the Internal Revenue code of 1986 to provide an additional year for the extension of the placed in service date for the low-income housing credit rules applicable to the GO Zone. S.146 Veteran Employment Transition Act of 2011
RegulationsMentioned in 40 dockets; Submitted to 6 dockets
All data is based on documents downloaded from Regulations.gov. The first table shows mentions: all documents that include the name of the company anywhere in the document or document metadata. The second table shows submissions: all documents where the submitter metadata included the company name. Each table shows the top 10 dockets, ranked by number of occurrences.
Matches are based on a search for the company name. Variations in the company name, such as acronyms, nicknames or alternate names may cause documents to be missed. The mention of a company name in a document may be incidental and does not necessarily indicate that the company has any relevance to the document. Company names that are common English words may erroneously match with text that is not referring to the company.
Not all agencies submit public comments to Regulations.gov. For a list of participating and non-participating agencies see here. Agencies that do submit to Regulations.gov have varying levels of accuracy and completeness.
Regulations and public comments can be downloaded in bulk here.
The tables show occurrences of "American Pharmacists Assn" in public comments on proposed federal regulations.
Documents Submitted by the Organization
View all submissions data for American Pharmacists Assn
- Toggle 2 DEA Disposal of Controlled Substances 2012
- Toggle 2 FDA Using Innovative Technologies and Other Conditions of Safe Use To Expand Which Drug Products Can Be Considered Nonprescription 2012
- Toggle 1 FDA Draft Blueprint for Prescriber Education for Long-Acting/Extended-Release Opioid Class-Wide Risk Evaluation and Mitigation Strategy; Availability; Request for Comments 2011
- Toggle 1 FDA Draft Guidances Relating to the Development of Biosimilar Products; Public Hearing; Request for Comments 2011
- Toggle 1 FDA Risk Evaluation and Mitigation Strategy Assessments: Social Science Methodologies to Assess Goals Related to Knowledge; Public Workshop; Issue Paper 2012
- Toggle 1 FDA Center for Drug Evaluation and Research, Approach to Addressing Drug Shortage; Public Workshop, Request for Comments 2011
Mentions in Document Text
View all mentions data for American Pharmacists Assn
- Toggle 9 FDA Using Innovative Technologies and Other Conditions of Safe Use To Expand Which Drug Products Can Be Considered Nonprescription 2012
- Toggle 5 CMS Medicare Program; Proposed Changes to the Medicare Advantage and the Medicare Prescription Drug Benefit Programs for Contract Year 2013 and Other Proposed Changes; Considering Changes to the Conditions of Participation for Long Term Care Facilities 2011
- Toggle 5 HHS Health Information Technology; HIT Policy Committee: Request for Comment Regarding the Stage 3 Definition of Meaningful Use of Electronic Health Records (EHRs) 2012
- Toggle 4 DEA Disposal of Controlled Substances 2012
- Toggle 3 HHS Health Information Technology; Implementation Specifications, and Certification Criteria: Electronic Health Record Technology, 2014 Edition 2012
- Toggle 3 HHS HIPAA Privacy Rule Accounting of Disclosures under the Health Information Technology for Economic and Clinical Health Act 2011
- Toggle 3 FDA Draft Guidances Relating to the Development of Biosimilar Products; Public Hearing; Request for Comments 2011
- Toggle 2 CMS Electronic Health Record Incentive Program – Stage 2 "Meaningful Use" 2012
- Toggle 2 HHS Nationwide Health Information Network: Conditions for Trusted Exchange 2012
- Toggle 2 FDA Draft Guidance for Industry on Safety Considerations for Product Design to Minimize Medication Errors; Availability 2012